Articles Eligibility and subsequent burden of cardiovascular disease of four strategies for blood pressurelowering treatment a retrospective cohort study

[Articles] Eligibility and subsequent burden of cardiovascular disease of four strategies for blood pressure-lowering treatment: a retrospective cohort study

19:55 EDT 25 Jul 2019 | The Lancet

A cardiovascular risk-based strategy (QRISK2 ≥10%) could prevent over a third more cardiovascular disease events than the 2011 NICE guideline and a fifth more than the 2019 NICE guideline, with similar efficiency regarding number treated per event avoided.

More From BioPortfolio on "[Articles] Eligibility and subsequent burden of cardiovascular disease of four strategies for blood pressure-lowering treatment: a retrospective cohort study"